featured-Reporter
-
August 9, 2012
Team creates new view of body’s infection response
A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases. -
August 9, 2012
Young patient’s cancer battle inspires hometown
Maryville, Tenn., tucked in the foothills of the Great Smoky Mountains, has a population of just 27,000, but it seemed like every one of its residents rallied around 20-year-old Brently Mancini when he was diagnosed with a rare soft tissue cancer. -
August 2, 2012
VHVI reaches milestone in heart valve procedures
Vanderbilt Heart and Vascular Institute recently performed its 100th transcatheter aortic heart valve-replacement (TAVR) on 91-year-old Murline Westover from Lavinia, Tenn. -
August 2, 2012
VUSM’s class of 2016 gets a jump on medical studies
July 23 was the first day of class for the VUSM class of 2016, a little more than a week earlier than the start of last year’s classes. -
August 2, 2012
Proteins may point way to new prostate cancer drug targets
Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found. -
August 2, 2012
VU study reveals connective tissue’s reinforcing ‘rivet’
An ancient enzyme that can be traced back 500 million years forms the chemical “rivet” that reinforces connective tissue throughout the body, Vanderbilt University researchers reported this week. -
July 31, 2012
National type I diabetes prevention trial now an option for younger children
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.